Evidence map›Paper›PMID 40931499›Full record

ArticleThe American journal of case reports2025

Progressive Vision Loss From Uveal Melanoma with Extraocular Extension: A Case Report.

Ana Paula F C Tupynambá, Heloisa Lima Heller, Maria Fernanda L Britto, Isabella F Macedo, José A G Torres Junior, Valéria L C Borges, Ana Beatriz C Vieira, Renata Batista Ostrowski, Gustavo Henrique Soares Takano, Leonardo C G B Oliveira

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana Paula F C TupynambáDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
Heloisa Lima HellerDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
Maria Fernanda L BrittoDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
Isabella F MacedoDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
José A G Torres JuniorDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
Valéria L C BorgesDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
Ana Beatriz C VieiraDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.
Renata Batista OstrowskiDepartment of Pathology, Brasília University Hospital, Brasília, DF, Brazil.
Gustavo Henrique Soares TakanoSchool of Medicine, University of Brasília, Brasília, DF, Brazil.
Leonardo C G B OliveiraDepartment of Ophthalmology, Brasília University Hospital, Brasília, DF, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Uveal melanoma is the most common primary intraocular malignancy in adults, often diagnosed late in resource-limited settings. The diagnosis is made through a combination of clinical ophthalmologic examination, B-mode ultrasound, and histopathological study. This report details a case of a 67-year-old woman with progressive vision loss and ocular pain due to an inferomedial uveal melanoma to highlight therapeutic limitations from delayed diagnosis. CASE REPORT A 67-year-old woman presented with 3 years of progressive vision loss, ocular pain, and a pigmented inferomedial lesion in the right eye. Examination revealed light perception vision, intraocular pressure of 38 mmHg, and a conjunctival mass with feeder vessels. Ultrasound showed a large choroidal tumor occupying 70% of the vitreous. Enucleation confirmed a 19-mm-thick mixed-cell uveal melanoma (T4a per American Joint Committee on Cancer 8th edition) with scleral invasion. Postoperative computed tomography (CT) revealed no metastases. CONCLUSIONS Delayed presentation led to enucleation as the only viable treatment. This case underscores the critical need for public awareness, early detection, and effective referral systems of pigmented ocular lesions to preserve vision, expand therapeutic options, and ensure timely access to specialized care.

Indexed as

BlindnessMelanomaUveal NeoplasmsVision DisordersAgedEye EnucleationFemaleHumansUveal Melanoma

Identifiers

PMID40931499
PMCPMC12439508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.